
Ep158: David Younger and Randolph Lopez on SynBio & AI for Discovery
The Long Run with Luke Timmerman
00:00
Exploring Yeast as a Platform for Drug Discovery
This chapter delves into the advantages of using yeast for drug discovery, focusing on expressing human proteins and optimizing antibodies. It also discusses the origins of the company, highlighting the importance of a strong technological foundation and the symbiotic skills of the co-founders.
Transcript
Play full episode